Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

First-Line Nivolumab Plus Ipilimumab in Unresectable Hepatocellular Carcinoma (J-PROMISE)

Bristol-Myers Squibb · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
hcchepatocellularcarcinomanivolumab
unresectable hepatocellular carcinoma, hepatocellular carcinoma; hcc; nivolumab; ipilimumab, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 886490
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.